Iovance Biotherapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IOVA and other ETFs, options, and stocks.

About IOVA

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). 

CEO
Frederick G. Vogt
CEOFrederick G. Vogt
Employees
975
Employees975
Headquarters
San Carlos, California
HeadquartersSan Carlos, California
Founded
2007
Founded2007
Employees
975
Employees975

IOVA Key Statistics

Market cap
3.76B
Market cap3.76B
Price-Earnings ratio
-11.49
Price-Earnings ratio-11.49
Dividend yield
Dividend yield
Average volume
19.55M
Average volume19.55M
High today
$9.30
High today$9.30
Low today
$8.15
Low today$8.15
Open price
$9.08
Open price$9.08
Volume
27.81M
Volume27.81M
52 Week high
$9.36
52 Week high$9.36
52 Week low
$1.76
52 Week low$1.76

Stock Snapshot

The current Iovance Biotherapeutics(IOVA) stock price is $8.28, with a market capitalization of 3.76B. The stock trades at a price-to-earnings (P/E) ratio of -11.49.

As of 2026-08-23, Iovance Biotherapeutics(IOVA) stock has fluctuated between $8.15 and $9.30. The current price stands at $8.28, placing the stock +1.7% above today's low and -11.0% off the high.

Iovance Biotherapeutics(IOVA) shares are trading with a volume of 27.81M, against a daily average of 19.55M.

In the last year, Iovance Biotherapeutics(IOVA) shares hit a 52-week high of $9.36 and a 52-week low of $1.76.

In the last year, Iovance Biotherapeutics(IOVA) shares hit a 52-week high of $9.36 and a 52-week low of $1.76.

IOVA News

Simply Wall St 2d
Does Iovance Have a Differentiated Edge in Next‑Gen TIL Platforms After IOV‑5001 Approval? - simplywall.st

...

Does Iovance Have a Differentiated Edge in Next‑Gen TIL Platforms After IOV‑5001 Approval? - simplywall.st
TipRanks 6d
Iovance Biotherapeutics put volume heavy and directionally bearish

Bearish flow noted in Iovance Biotherapeutics (IOVA) with 5,753 puts trading, or 6x expected. Most active are Aug-26 7 puts and Sep-26 7.5 calls, with total vol...

Analyst ratings

78%

of 9 ratings
Buy
77.8%
Hold
22.2%
Sell
0%

People also own

Based on the portfolios of people who own IOVA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.